QIAseq Targeted DNA Sequencing Panels

Digital DNA sequencing to confidently detect low-frequency variants

QIAseq Targeted DNA Panel (12)

Cat no. / ID. 333502

Kit containing ALL reagents (except indexes) for targeted DNA sequencing; fixed panel for 12 samples; less than 100 genes

Browse product options to see pricing

Panel

QIAseq Targeted DNA Panel (standard)

QIAseq Targeted DNA Pro Panel

QIAseq Targeted cfDNA Ultra Panel

Panel type

Fixed

Custom

Size

Useful links

Below you can find a set of references related to QIAseq Targeted DNA Panels

Popular Products	GeneGlobe ID
QIAseq Targeted DNA Human Actionable Solid Tumor Panel	DHS-101Z
QIAseq Targeted DNA Human Breast Cancer Panel	DHS-001Z
QIAseq Targeted DNA Human BRCA1 and BRCA2 Panel	DHS-102Z
QIAseq Targeted DNA Human HRR Panel	DHS-110Z
QIAseq Targeted DNA Human Pharmacogenomics Panel	DHS-104Z

Explore Our Full Product Range

Dive into our extensive catalog of QIAseq Targeted DNA Panel (12) to find the perfect fit for your research needs. Browse our full selection and discover the ideal solution for your project.

Browse 30 variants

Features

Confident low-frequency variant detection with molecular barcodes and UMIs
Efficient target enrichment, including challenging GC-rich regions
Flexible options for tissue, FFPE and cfDNA samples
Standard, Pro and cfDNA Ultra workflows for different research needs
Catalog and custom panel designs

Product Details

QIAseq Targeted DNA Sequencing Panels offer three options built on a shared digital DNA sequencing foundation.

	QIAseq Targeted DNA Panel	QIAseq Targeted DNA Pro Panel	QIAseq Targeted cfDNA Ultra Panel
Best for	A proven, versatile starting point for targeted DNA sequencing across diverse sample types	Faster, automation-friendly targeted DNA sequencing with expanded variant analysis	Ultra-sensitive targeted sequencing for detecting extremely rare variants in cell-free DNA (cfDNA) from blood for liquid biopsy research
Ideal sample	DNA from tissue, blood, FFPE or cfDNA	DNA from tissue, blood, FFPE and cfDNA	Cell-free DNA (cfDNA)
Sensitivity	Reliable detection of low-frequency variants (SNVs, small indels, CNVs, select structural variants with characterized breakpoints, LOH), >90% sensitivity on detecting small variants down to 0.5%	Reliable detection of low-frequency variants (SNVs, small indels, CNVs, select structural variants with characterized breakpoints, LOH), >90% sensitivity on detecting small variants down to 0.5%	Ultra-low-frequency somatic variant detection, down to 0.1% VAF, with >99% specificity
Input needed	10–80 ng (up to 250 ng FFPE)	10–80 ng (up to 250 ng FFPE)	As little as 5–80 ng cfDNA
Time to library	~ 9 hours	~ 6 hours	~8 hours
Hands-on time	~3 hours	~1.5 hours	~2 hours
Sequencing platforms	Illumina, Ion Torrent, Element Biosciences	Illumina, Ion Torrent, Element Biosciences	Illumina, Element Biosciences
Catalog numbers	Fixed (12, 96): 333502, 333505 Custom (96): 333525	Fixed (12, 96): 333651, 333655 Custom (96): 333675	Fixed (12, 96): 334051, 334055 Custom (96): 334405, 334455

*Sizes indicate the number of reactions per kit.

Performance

QIAseq Targeted DNA Sequencing Panels combine molecular barcoding with highly specific target enrichment for sensitive, reliable detection of low-frequency variants.

QIAseq Targeted DNA Panels:
Accuracy and sensitivity. Molecular barcodes help reduce PCR and sequencing errors. In QIAGEN testing, panels achieved >90% sensitivity for NA12878 SNPs and indels at 1% variant frequency, with<15 false positives per megabase under specified tiled-primer conditions.
Specificity and uniformity. Optimized enrichment delivers highly specific, uniform coverage, including challenging GC-rich regions.
Flexibility. Supports SNVs, small indels and CNVs, with catalog and custom designs for exons, hotspots, SNPs, intronic regions and promoters.
Workflow. The workflow from extracted DNA to sequencing-ready libraries can be completed in 9 hours.

QIAseq Targeted DNA Pro Panels:
Sensitive variant detection. Integrated UMIs support confident detection of known and novel variants.
Challenging samples. Built-in FFPE repair and optimized chemistry support fragmented DNA and GC-rich targets.
Faster workflow. Sequencing-ready libraries in <6 hours with minimal hands-on time and automation-friendly enzymatic cleanup.
Expanded variant analysis. Supports SNVs, small indels, CNVs, select structural variants and lossof heterozygosity (LOH).

QIAseq Targeted cfDNA Ultra Panels:
Ultra-sensitive detection. Detects variants down to 0.1% VAF using integrated UMIs, high-fidelity chemistry and error correction.
High specificity and uniformity. Delivers >99% specificity with QIAGEN CLC Genomics Workbench, with >99% coverage uniformity and >90% target specificity in supporting data.
Low-input, high-multiplex performance. Uses 5–80 ng human cfDNA and supports up to 20,000 primers per panel, including GC-rich targets.
Efficient workflow. Sequencing-ready libraries within 8 hours with <2 hours of hands-on time.

Principle

PCR duplicates and errors introduced during amplification and sequencing can make it difficult to confidently detect variants present at low frequencies in the starting DNA.

All QIAseq Targeted DNA Sequencing workflows leverage UMI-enabled digital DNA sequencing and Single Primer Extension (SPE) technology to deliver highly specific target enrichment and confident variant detection.

Procedure

QIAseq Targeted DNA Sequencing Panels follow a streamlined workflow from extracted DNA to variant analysis, with specific steps and sequencing options depending on the panel family.

Start with your DNA. Use DNA from supported sample types, including tissue, FFPE, plasma/serum or cell-free DNA (cfDNA), depending on the panel.
Add molecular barcodes. Unique molecular indices (UMIs) tag original DNA molecules before target amplification, helping distinguish true variants from PCR and sequencing errors.
Enrich your targets. QIAseq single-primer enrichment selectively amplifies the genes and regions included in your panel.
Index and sequence. Add sample indices for multiplexing, then sequence on a compatible Illumina or Ion Torrent platform, depending on the panel family.
Analyze and interpret. Use QIAseq analysis solutions or QIAGEN CLC Genomics Workbench for barcode-aware variant calling, with QCI Interpret available for further variant annotation and interpretation.

Applications

QIAseq Targeted DNA Sequencing Panels can be used to analyze a variety of DNA variants across a range of sample types and research applications. Supported capabilities vary by panel family.

DNA variants

SNVs
Small indels
CNVs
Select structural variants with well-characterized breakpoints
Loss of heterozygosity (LOH)

Sample types

FFPE
Plasma/serum
Fresh or frozen tissue
Cell lines
Human cell-free DNA (cfDNA)*

Applications

Profiling DNA variants in solid and hematologic malignancies
Hotspot detection in solid tumors
Examination of variants in mitochondrial DNA
Pain and ADME pharmacogenomics
Human identity and paternity testing
Assessment of germline variants for inherited diseases
Profiling of exonic regions in BRCA1 and BRCA2
Liquid biopsy and early cancer profiling*
Minimal residual disease (MRD) research*
Research into treatment resistance*

*QIAseq Targeted cfDNA Ultra Panels are designed specifically for human cfDNA.

Supporting data and figures

Workflow

Isolated DNA, as low as 20 ng, is enzymatically fragmented to generate small pieces of dsDNA. This is followed by the library construction step, in which IL-N7 adapters, molecular barcodes, and sample indexes are incorporated into DNA fragments generated in the previous step. Library fragments now serve as templates for target enrichment using QIAseq Enrichment Technology. In this step, targets are enriched using a single gene-specific primer and a universal forward primer. The final step is library amplification and sample indexing (for dual indexing) using the IL-S5 sample index primer and a universal primer.

High specificity (>90%) and uniformity of coverage (>99%) across panels.

Resources

Unlock the potential of next-generation sequencing with QIAseq comprehensive solutions

Expert insights

Next-generation sequencing using QIAGEN’s QIAseq – a powerful tool for human identification

Advanced sample collection, automation and STR solutions for kinship testing

State-of-the-art technologies to fast-track and streamline NGS workflows

For ultrasensitive targeted next-generation sequencing (NGS) of DNA for Illumina^® NGS systems

For ultrasensitive targeted next-generation sequencing (NGS) of DNA for Ion Torrent NGS systems

The use of UMIs as part of a QIAseq targeted sequencing panel

Download Safety Data Sheets for QIAGEN product components.

Publications

Non-invasive detection of actionable mutations in advanced non-small-cell lung cancer using targeted sequencing of circulating tumor DNA.

Sim WC; Loh CH; Toh GL; Lim CW; Chopra A; Chang AYC; Goh LL;

Lung Cancer; 2018; 124:154-159 2018 Aug 8 PMID:30268455

smCounter2: an accurate low-frequency variant caller for targeted sequencing data with unique molecular identifiers.

Xu C; Gu X; Padmanabhan R; Wu Z; Peng Q; DiCarlo J; Wang Y;

Bioinformatics; 2019; 35 (8):1299-1309 2019 Apr 15 PMID:30192920

Correlation of genomic alterations between tumor tissue and circulating tumor DNA by next-generation sequencing.

Chang YS; Fang HY; Hung YC; Ke TW; Chang CM; Liu TY; Chen YC; Chao DS; Huang HY; Chang JG;

J Cancer Res Clin Oncol; 2018; 144 (11):2167-2175 2018 Sep 10 PMID:30203147

Detecting very low allele fraction variants using targeted DNA sequencing and a novel molecular barcode-aware variant caller.

Xu C; Nezami Ranjbar MR; Wu Z; DiCarlo J; Wang Y;

BMC Genomics; 2017; 18 (1):5 2017 Jan 3 PMID:28049435

Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.

Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF;

Am J Surg Pathol; 2018; 42 (11):1530-1540 2018 Nov PMID:30001242

TB Management

Transplant

Infectious Disease

Oncology

Sexual & Reproductive Health

Sample Processing

Solutions for Laboratory-Developed Tests

QIAseq Targeted DNA Sequencing Panels

Digital DNA sequencing to confidently detect low-frequency variants